Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IA › Harlan › NPI 1598871469
Hospital

Shelby County Chris a Myrtue Memorial Hospital

Shelby County Chris a Myrtue Memorial Hospital was paid $1.51M by Medicaid between Jan 2018 and Dec 2024, across 41 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.

33Billing provider infoSHELBY COUNTY CHRIS A MYRTUE MEMORIAL HOSPITAL
HARLAN, IA 51537
33aNPI1598871469assigned 08/22/2006
33bProvider typeCritical Access Hospital
28Total paid$1.51M
24GClaims45,635
24DCodes billed41
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Iowa

Rank by total paid#25 of 79
Median peer was paid$801K
This provider vs. median1.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20186,375$147K
20196,353$160K
20205,874$180K
20216,117$214K
20228,394$331K
20237,300$276K
2024incomplete5,222$198K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 31% 7,033 5,924 $460K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 14% 7,736 6,563 $209K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 14% 5,539 5,324 $205K
80053 Comprehensive metabolic panel 12% 3,719 3,372 $184K
36415 Collection of venous blood by venipuncture 12% 14,712 12,357 $174K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 4.4% 1,493 1,441 $66K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 2.3% 381 323 $34K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 1.8% 952 925 $27K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.7% 245 232 $26K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.7% 204 193 $25K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1.6% 220 207 $24K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 506 436 $11K
29 more codes
87086 Culture, bacterial; quantitative colony count, urine <1% 258 $8K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 151 $7K
95117 <1% 1,142 $6K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 88 $5K
80048 Basic metabolic panel (calcium, ionized) <1% 156 $5K
87807 <1% 167 $4K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 30 $3K
84443 Thyroid stimulating hormone (TSH) <1% 55 $3K
87480 <1% 36 $3K
81002 <1% 197 $3K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 196 $2K
87660 <1% 36 $2K
87510 <1% 36 $2K
85018 <1% 40 $1K
71046 Radiologic examination, chest; 2 views <1% 25 $994.50
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 13 $857.70
81003 <1% 32 $787.34
83655 <1% 27 $618.29
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 36 $446.33
80061 Lipid panel <1% 12 $388.76
96375 Therapeutic injection; each additional sequential IV push <1% 14 $375.58
86308 <1% 13 $304.64
J2704 Injection, propofol, 10 mg <1% 16 $287.98
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 29 $286.72
86850 <1% 12 $275.86
81001 <1% 15 $254.04
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 39 $237.71
86900 <1% 12 $236.00
86901 <1% 12 $236.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJACOBSEN, BARRY (CEO)
Same official

Other billing entities under JACOBSEN, BARRY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.